- $1.83bn
- $4.21bn
- $752.29m
- 80
- 64
- 86
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 459 | 471 | 513 | 670 | 752 |
Cost of Revenue | |||||
Gross Profit | 324 | 315 | 357 | 482 | 571 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 321 | 607 | 271 | 395 | 512 |
Operating Profit | 138 | -136 | 243 | 275 | 240 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 89.2 | -224 | 164 | 203 | 87.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 89.2 | -224 | 164 | 203 | 83.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 89.2 | -224 | 164 | 203 | 83.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 89.2 | -224 | 164 | 203 | 83.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.39 | 0.96 | 0.91 | 1.38 | 0.577 |
Dividends per Share |